December 2017 - Volume 27 - Issue 6
pp: 527-652

Basic research


Resistance mechanisms to genetic suppression of mutant NRAS in melanoma

Robinson, James P.; Rebecca, Vito W.; Kircher, David A.; More

Melanoma Research. 27(6):545-557, December 2017.

Translational research


A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions

Martínez-García, Miguel Ángel; Riveiro-Falkenbach, Erica; Rodríguez-Peralto, José L.; More

Melanoma Research. 27(6):558-564, December 2017.

Clinical research


Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E

Hallmeyer, Sigrun; Gonzalez, Rene; Lawson, David H.; More

Melanoma Research. 27(6):585-590, December 2017.

Epidemiology of melanoma


Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)

Grange, Florent; Mohr, Peter; Harries, Mark; More

Melanoma Research. 27(6):607-618, December 2017.

Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of...

Borghi, Alessandro; Corazza, Monica; Virgili, Annarosa; More

Melanoma Research. 27(6):619-624, December 2017.


Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination

Lupu, Jeremy; Pages, Cécile; Laly, Pauline; More

Melanoma Research. 27(6):649-652, December 2017.